Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors

5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine resid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 1992-07, Vol.42 (1), p.94-102
Hauptverfasser: VICKERS, P. J, ADAM, M, CHARLESON, S, COPPOLINO, M. G, EVANS, J. F, MANCINI, J. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102
container_issue 1
container_start_page 94
container_title Molecular pharmacology
container_volume 42
creator VICKERS, P. J
ADAM, M
CHARLESON, S
COPPOLINO, M. G
EVANS, J. F
MANCINI, J. A
description 5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands. Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62 may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_16336078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16336078</sourcerecordid><originalsourceid>FETCH-LOGICAL-h295t-ca9afc59afa8a4c91e456fd544fc3d6f610bf141f3e0d5437042ea6e66cba1123</originalsourceid><addsrcrecordid>eNpFkN1KJDEQhRtZ0fHnERZyIXvXkHR-ZvpyEXdXELxR8K6pTlemS7uTMcmszjP40pvBwb2pglPfOVTVUbUQuhE1F0J8qxacN6ZetfrptDpL6ZlzofSKn1QnwkittVlUH7cD-kyOLGQKngXHYCYfGFgaWMREwxbTXtb1RJvwvlujh4Q12Ex_i8ev2SaGjOQZprTPgom5EFkekfXkhz1R7BNuX0KOhH4vh7TzBUiUGPmResohpovq2MGU8PLQz6vHXzcP13_qu_vft9c_7-qxaXWuLbTgrC4FVqBsK1Bp4watlLNyMM4I3juhhJPIiyqXXDUIBo2xPQjRyPPqx2duWfy1XJe7mZLFaQKPYZu68hxp-HJVwO8HcNvPOHSbSDPEXXf4XplfHeaQLEwugreUvjCtl1K2y__YSOvxjSJ2mxHiDDZMYb3rVNOJrlXyH_Swimw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16336078</pqid></control><display><type>article</type><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</creator><creatorcontrib>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</creatorcontrib><description>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands. Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62 may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>PMID: 1635556</identifier><identifier>CODEN: MOPMA3</identifier><language>eng</language><publisher>Bethesda, MD: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>5-lipoxygenase-activating protein ; 5-Lipoxygenase-Activating Proteins ; Affinity Labels ; Amino Acid Sequence ; amino acids ; Amino Acids - metabolism ; Analytical, structural and metabolic biochemistry ; Azides - metabolism ; binding ; Binding, Competitive ; Biological and medical sciences ; Blotting, Western ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cell Line ; Fatty acids ; Fundamental and applied biological sciences. Psychology ; Genetic Vectors ; Humans ; identification ; Indoles - metabolism ; inhibitors ; leukotriene ; Leukotrienes - biosynthesis ; Lipids ; Membrane Proteins - genetics ; Membrane Proteins - metabolism ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Other biological molecules ; Precipitin Tests ; Quinolines - metabolism ; Radioligand Assay ; site-directed mutagenesis ; synthesis</subject><ispartof>Molecular pharmacology, 1992-07, Vol.42 (1), p.94-102</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5573397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1635556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VICKERS, P. J</creatorcontrib><creatorcontrib>ADAM, M</creatorcontrib><creatorcontrib>CHARLESON, S</creatorcontrib><creatorcontrib>COPPOLINO, M. G</creatorcontrib><creatorcontrib>EVANS, J. F</creatorcontrib><creatorcontrib>MANCINI, J. A</creatorcontrib><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands. Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62 may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</description><subject>5-lipoxygenase-activating protein</subject><subject>5-Lipoxygenase-Activating Proteins</subject><subject>Affinity Labels</subject><subject>Amino Acid Sequence</subject><subject>amino acids</subject><subject>Amino Acids - metabolism</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Azides - metabolism</subject><subject>binding</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell Line</subject><subject>Fatty acids</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Vectors</subject><subject>Humans</subject><subject>identification</subject><subject>Indoles - metabolism</subject><subject>inhibitors</subject><subject>leukotriene</subject><subject>Leukotrienes - biosynthesis</subject><subject>Lipids</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Other biological molecules</subject><subject>Precipitin Tests</subject><subject>Quinolines - metabolism</subject><subject>Radioligand Assay</subject><subject>site-directed mutagenesis</subject><subject>synthesis</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkN1KJDEQhRtZ0fHnERZyIXvXkHR-ZvpyEXdXELxR8K6pTlemS7uTMcmszjP40pvBwb2pglPfOVTVUbUQuhE1F0J8qxacN6ZetfrptDpL6ZlzofSKn1QnwkittVlUH7cD-kyOLGQKngXHYCYfGFgaWMREwxbTXtb1RJvwvlujh4Q12Ex_i8ev2SaGjOQZprTPgom5EFkekfXkhz1R7BNuX0KOhH4vh7TzBUiUGPmResohpovq2MGU8PLQz6vHXzcP13_qu_vft9c_7-qxaXWuLbTgrC4FVqBsK1Bp4watlLNyMM4I3juhhJPIiyqXXDUIBo2xPQjRyPPqx2duWfy1XJe7mZLFaQKPYZu68hxp-HJVwO8HcNvPOHSbSDPEXXf4XplfHeaQLEwugreUvjCtl1K2y__YSOvxjSJ2mxHiDDZMYb3rVNOJrlXyH_Swimw</recordid><startdate>19920701</startdate><enddate>19920701</enddate><creator>VICKERS, P. J</creator><creator>ADAM, M</creator><creator>CHARLESON, S</creator><creator>COPPOLINO, M. G</creator><creator>EVANS, J. F</creator><creator>MANCINI, J. A</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope></search><sort><creationdate>19920701</creationdate><title>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</title><author>VICKERS, P. J ; ADAM, M ; CHARLESON, S ; COPPOLINO, M. G ; EVANS, J. F ; MANCINI, J. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h295t-ca9afc59afa8a4c91e456fd544fc3d6f610bf141f3e0d5437042ea6e66cba1123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>5-lipoxygenase-activating protein</topic><topic>5-Lipoxygenase-Activating Proteins</topic><topic>Affinity Labels</topic><topic>Amino Acid Sequence</topic><topic>amino acids</topic><topic>Amino Acids - metabolism</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Azides - metabolism</topic><topic>binding</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell Line</topic><topic>Fatty acids</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Vectors</topic><topic>Humans</topic><topic>identification</topic><topic>Indoles - metabolism</topic><topic>inhibitors</topic><topic>leukotriene</topic><topic>Leukotrienes - biosynthesis</topic><topic>Lipids</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Other biological molecules</topic><topic>Precipitin Tests</topic><topic>Quinolines - metabolism</topic><topic>Radioligand Assay</topic><topic>site-directed mutagenesis</topic><topic>synthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VICKERS, P. J</creatorcontrib><creatorcontrib>ADAM, M</creatorcontrib><creatorcontrib>CHARLESON, S</creatorcontrib><creatorcontrib>COPPOLINO, M. G</creatorcontrib><creatorcontrib>EVANS, J. F</creatorcontrib><creatorcontrib>MANCINI, J. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VICKERS, P. J</au><au>ADAM, M</au><au>CHARLESON, S</au><au>COPPOLINO, M. G</au><au>EVANS, J. F</au><au>MANCINI, J. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>1992-07-01</date><risdate>1992</risdate><volume>42</volume><issue>1</issue><spage>94</spage><epage>102</epage><pages>94-102</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><coden>MOPMA3</coden><abstract>5-Lipoxygenase-activating protein (FLAP) is specifically labeled by [125I]L-669,083 and [125I]L-691,678, photoaffinity analogues of two classes of potent leukotriene biosynthesis inhibitors. Because human FLAP contains only a single tryptophan residue at position 72 and two internal methionine residues at positions 89 and 125, we have used reagents that specifically cleave at these residues, in conjunction with antipeptide antisera, to localize the site of attachment of the photoaffinity ligands. Immunoprecipitation of specifically labeled peptide fragments after digestion of photoaffinity-labeled FLAP by iodosobenzoic acid at 72Trp demonstrates that the inhibitors bind to FLAP amino-terminal to this residue. This finding is consistent with similar immunoprecipitation studies after digestion at methionine residues using cyanogen bromide. These findings localize the site of attachment of the inhibitors to a region of FLAP that includes the hydrophilic loop between the proposed first and second transmembrane regions. Based on these findings, site-directed mutagenesis of human FLAP was performed to define key amino acids involved in inhibitor binding. Using a radioligand binding assay, analysis of mutants of human FLAP expressed in COS-7 cells demonstrates that a number of residues in the amino-terminal half of the first hydrophilic loop of the protein can be deleted without significantly affecting inhibitor binding. In contrast, no inhibitor binding was detectable with mutants in which amino acid residues in the carboxyl-terminal half of this loop were deleted. Furthermore, a point mutation of 62Asp to asparagine results in a mutant with dramatically reduced affinity for inhibitors. This loss of affinity was not displayed by a mutant in which 62Asp was mutated to a glutamate residue, suggesting that a negative charge associated with residue 62 may be critical for inhibitor binding. The roles that amino acid residues in the carboxyl-terminal half of the first hydrophilic loop of FLAP may play in the binding of leukotriene biosynthesis inhibitors are currently under investigation.</abstract><cop>Bethesda, MD</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>1635556</pmid><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 1992-07, Vol.42 (1), p.94-102
issn 0026-895X
1521-0111
language eng
recordid cdi_proquest_miscellaneous_16336078
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 5-lipoxygenase-activating protein
5-Lipoxygenase-Activating Proteins
Affinity Labels
Amino Acid Sequence
amino acids
Amino Acids - metabolism
Analytical, structural and metabolic biochemistry
Azides - metabolism
binding
Binding, Competitive
Biological and medical sciences
Blotting, Western
Carrier Proteins - genetics
Carrier Proteins - metabolism
Cell Line
Fatty acids
Fundamental and applied biological sciences. Psychology
Genetic Vectors
Humans
identification
Indoles - metabolism
inhibitors
leukotriene
Leukotrienes - biosynthesis
Lipids
Membrane Proteins - genetics
Membrane Proteins - metabolism
Molecular Sequence Data
Mutagenesis, Site-Directed
Other biological molecules
Precipitin Tests
Quinolines - metabolism
Radioligand Assay
site-directed mutagenesis
synthesis
title Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A41%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20amino%20acid%20residues%20of%205-lipoxygenase-activating%20protein%20essential%20for%20the%20binding%20of%20leukotriene%20biosynthesis%20inhibitors&rft.jtitle=Molecular%20pharmacology&rft.au=VICKERS,%20P.%20J&rft.date=1992-07-01&rft.volume=42&rft.issue=1&rft.spage=94&rft.epage=102&rft.pages=94-102&rft.issn=0026-895X&rft.eissn=1521-0111&rft.coden=MOPMA3&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E16336078%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16336078&rft_id=info:pmid/1635556&rfr_iscdi=true